Which has grown faster, MRNA or ZBH?

Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus ZBH at 4.21%.

Does MRNA or ZBH pay a bigger dividend?

ZBH pays a dividend (1.00% yield), while MRNA has no payments in the available dividend history.

Is MRNA or ZBH more profitable?

ZBH runs the higher net margin — MRNA at -143.55% versus ZBH at 9.05%.

How have MRNA and ZBH total returns compared?

Over the past 5 years, MRNA delivered -30.71% and ZBH delivered -1.72% annualized total return. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Zimmer Biomet Holdings, Inc. (ZBH)

A side-by-side comparison of Moderna, Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

MRNA

Moderna, Inc.

$21.92B

$55.25HealthcareDelayed quote: Jul 29, 2026, 2:40 PM EDT

ZBH

Zimmer Biomet Holdings, Inc.

$18.70B

$96.66HealthcareDelayed quote: Jul 29, 2026, 2:40 PM EDT

Total return — MRNA vs ZBH

growth of $100 · dividends reinvested · last 8y

MRNA +200.1%ZBH -6.1%MRNA compounded faster

MRNA ZBH

MRNA vs ZBH: by the numbers

•MRNA is the larger company ($21.92B vs $18.70B market cap).
•ZBH is profitable (9.05% net margin) while MRNA runs a net loss (-143.55%).
•MRNA grew revenue faster over the past five years (19.33% vs 4.21% CAGR).
•ZBH pays a dividend (1.00% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MRNA	ZBH
P/E ratio	N/A	24.87
Forward P/E	N/A	11.28
P/S ratio	9.91	2.23
P/B ratio	2.98	1.48
EV / EBITDA	N/A	11.15
FCF yield	N/A	9.79%

Profitability

Metric	MRNA	ZBH
Gross margin	55.35%	61.62%
Operating margin	-153.35%	15.61%
Net margin	-143.55%	9.05%
ROE	-43.12%	6.01%
ROIC	-29.70%	5.48%

Dividends

Metric	MRNA	ZBH
Dividend yield	N/A	1.00%
Payout ratio	N/A	26.97%

Growth (annualized)

Metric	MRNA	ZBH
Revenue CAGR (5Y)	19.33%	4.21%
FCF CAGR (5Y)	N/A	15.41%
Total return CAGR (5Y)	-30.71%	-8.72%

Frequently asked

Which has grown faster, MRNA or ZBH?: Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus ZBH at 4.21%.
Does MRNA or ZBH pay a bigger dividend?: ZBH pays a dividend (1.00% yield), while MRNA has no payments in the available dividend history.
Is MRNA or ZBH more profitable?: ZBH runs the higher net margin — MRNA at -143.55% versus ZBH at 9.05%.
How have MRNA and ZBH total returns compared?: Over the past 5 years, MRNA delivered -30.71% and ZBH delivered -1.72% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full ZBH analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio Zimmer Biomet P/E ratio Moderna dividend yield Zimmer Biomet dividend yield Moderna ROE Zimmer Biomet ROE Moderna operating margin Zimmer Biomet operating margin Moderna revenue growth Zimmer Biomet revenue growth Moderna free cash flow Zimmer Biomet free cash flow

Moderna & Zimmer Biomet appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.